Moreover, SOX11 and its hypermethylation were reported to be involved in the progression of head and neck cancer [57], cervical cancer [58], prostate cancer [59], etc. Wang et al. [60] proved that miR-31 modulates EMT in papillary thyroid carcinoma by targeting SOX11. Here, SOX11 is linked to prostate carcinoma.